What does Senti Biosciences Holdings, Inc. do?
Senti Biosciences Holdings, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The company's lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK)…
What is Senti Biosciences Holdings, Inc.'s P/E and P/B ratio?
Senti Biosciences Holdings, Inc. has a P/E ratio of -0.1 and a P/B ratio of -1.74.
What is Senti Biosciences Holdings, Inc.'s debt-to-equity ratio?
Senti Biosciences Holdings, Inc. has a debt-to-equity ratio of 5.17.
How much does Senti Biosciences Holdings, Inc. owe compared with what it owns?
Senti Biosciences Holdings, Inc. owes $1.10 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is Senti Biosciences Holdings, Inc.'s Positivity rank?
Senti Biosciences Holdings, Inc. is ranked #6,513 of 6,774 companies globally and #3,761 of 4,000 in United States on PositoAI, with a Positivity Score of -22,235.
Does Senti Biosciences Holdings, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Yes. Senti Biosciences Holdings, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 02 Sep 2026). It has no yellow flags.
Where can I read the latest news about Senti Biosciences Holdings, Inc.?
Recent headlines about Senti Biosciences Holdings, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Senti Biosciences Holdings, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Senti Biosciences Holdings, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.